Literature Citations
1. Anthelmintic and Antimycobacterial Activity of Fractions and Compounds Isolated from Cissampelos mucronata. Akande, R.T., G. Fouche, I.M. Famuyide, F.N. Makhubu, S.M. Nkadimeng, A.O. Aro, P.N. Kayoka-Kabongo, and L.J. McGaw. Journal of Ethnopharmacology, 2022. 292: 115130. PMID[35292375].
[PubMed]. TB_05_2022.
2. Structure-Activity Relationship of 2-Aminodibenzothiophene Pharmacophore and the Discovery of Aminobenzothiophenes as Potent Inhibitors of Mycobacterium smegmatis. Alelaiwi, S.H., J.E. Heindl, V. Sivaganesh, B. Peethambaran, and J.R. McKee. Bioorganic & Medicinal Chemistry Letters, 2022. 63: 128650. PMID[35245664].
[PubMed]. TB_05_2022.
3. Chemometric Investigation and Antimicrobial Activity of Salvia rosmarinus Spenn Essential Oils. Annemer, S., A. Farah, H. Stambouli, A. Assouguem, M.H. Almutairi, A.A. Sayed, I. Peluso, T. Bouayoun, N.A. Talaat Nouh, A. El Ouali Lalami, and Y. Ez Zoubi. Molecules, 2022. 27(9): 2914. PMID[35566267]. PMCID[PMC9099978].
[PubMed]. TB_05_2022.
4. Design, Synthesis and Biological Evaluation of N-phenylindole Derivatives as Pks13 Inhibitors Against Mycobacterium tuberculosis. Cai, Y., W. Zhang, S. Lun, T. Zhu, W. Xu, F. Yang, J. Tang, W.R. Bishai, and L. Yu. Molecules, 2022. 27(9): 2844. PMID[35566191]. PMCID[PMC9106008].
[PubMed]. TB_05_2022.
5. Spiropyrimidinetrione DNA Gyrase Inhibitors with Potent and Selective Antituberculosis Activity. Govender, P., R. Müller, K. Singh, V. Reddy, C.J. Eyermann, S. Fienberg, S.R. Ghorpade, L. Koekemoer, A. Myrick, D. Schnappinger, C. Engelhart, J. Meshanni, J.A.W. Byl, N. Osheroff, V. Singh, K. Chibale, and G.S. Basarab. Journal of Medicinal Chemistry, 2022. 65(9): p. 6903-6925. PMID[35500229].
[PubMed]. TB_05_2022.
6. Design, Synthesis and Antibacterial Activity against Pathogenic Mycobacteria of Conjugated Hydroxamic Acids, Hydrazides and O-Alkyl/O-Acyl Protected Hydroxamic Derivatives. Mavrikaki, V., A. Pagonis, I. Poncin, I. Mallick, S. Canaan, V. Magrioti, and J.F. Cavalier. Bioorganic & Medicinal Chemistry Letters, 2022. 64: 128692. PMID[35307568].
[PubMed]. TB_05_2022.
7. New Quinoline-urea-benzothiazole Hybrids as Promising Antitubercular Agents: Synthesis, in Vitro Antitubercular Activity, Cytotoxicity Studies, and in Silico ADME Profiling. Moodley, R., C. Mashaba, G.H. Rakodi, N.B. Ncube, M.V. Maphoru, M.O. Balogun, A. Jordan, D.F. Warner, R. Khan, and M. Tukulula. Pharmaceuticals, 2022. 15(5): 576. PMID[35631402]. PMCID[PMC9146500].
[PubMed]. TB_05_2022.
8. Anti-Mycobacterium abscessus Activity of Tuberculosis F-ATP Synthase Inhibitor GaMF1. Ragunathan, P., T. Dick, and G. Grüber. Antimicrobial Agents and Chemotherapy, 2022. 66(5): e0001822. PMID[35481752]. PMCID[PMC9112937].
[PubMed]. TB_05_2022.
9. Synthesis and Antimycobacterial Evaluation of Fluoroquinolones Derivatives Coupled with Isoprenyl Moiety at the C-7 Position. Ribeiro, C.A., D.B. dos Reis, I.F. Reis, A.N. de Carvalho, M.C.S. Lourenco, M.V.N. de Souza, A.C. Pinheiro, and M.F. Saraiva. Medicinal Chemistry Research, 2022. 31: p. 949-959. ISI[000788951500001].
[WOS]. TB_05_2022.
10. A Novel Class of Antimicrobial Drugs Selectively Targets a Mycobacterium tuberculosis PE-PGRS Protein. Seo, H., S. Kim, H.A. Mahmud, M.I. Islam, Y. Yoon, H.D. Cho, K.W. Nam, J. Choi, Y.S. Gil, B.E. Lee, and H.Y. Song. Plos Biology, 2022. 20(5): e3001648. PMID[35639773]. PMCID[PMC9154192].
[PubMed]. TB_05_2022.
11. Synthesis, Characterization and Complex Evaluation of Antibacterial Activity and Cytotoxicity of New Arylmethylidene Ketones and Pyrimidines with Camphane Skeletons. Slavchev, I.M., Y. Mitrev, B. Shivachev, V. Valcheva, M. Dogonadze, N. Solovieva, A. Vyazovaya, I. Mokrousov, W. Link, L. Jimenez, B. Cautain, T.A. Mackenzie, I. Portugal, F. Lopes, R. Capela, J. Perdigao, and G.M. Dobrikov. ChemistrySelect, 2022. 7(17): e202201339. ISI[000789871000001].
[WOS]. TB_05_2022.
12. In Vitro Antimycobacterial Activity of Medicinal Plants Lantana camara, Cryptolepis sanguinolenta, and Zanthoxylum leprieurii. Tuyiringire, N., I. Taremwa Mugisha, D. Tusubira, J.P. Munyampundu, C. Mambo Muvunyi, and Y. Vander Heyden. Journal of Clinical Tuberculosis and Mycobacterial Diseases, 2022. 27: 100307. PMID[35284659]. PMCID[PMC8904236].
[PubMed]. TB_05_2022.
13. Discovery and Biosynthesis of Antimicrobial Phenethylamine Alkaloids from the Marine Flavobacterium Tenacibaculum discolor sv11. Wang, L., V. Linares-Otoya, Y. Liu, U. Mettal, M. Marner, L. Armas-Mantilla, S. Willbold, T. Kurtán, L. Linares-Otoya, and T.F. Schäberle. Journal of Natural Products, 2022. 85(4): p. 1039-1051. PMID[35416664].
[PubMed]. TB_05_2022.
Patent Citations
14. Bicyclic Heterocyclic Compounds for Treatment of Tuberculosis. Reddy, G.S., R.K. Edwin, P. Misra, and M. Pal. Patent. 2022. 2021-IN51081 2022107167: 34pp.
[Patent]. TB_05_2022.